Mick Cochran’s practice is primarily focused on private equity and venture capital with a concentration on mergers and acquisitions, corporate finance, and distressed transactions. He represents buyers, sellers, and financiers in their investing activities and financing needs. Mick’s private equity and hedge fund practice focuses on fund formation, growth equity, management buyouts, recapitalizations, and spinouts.
Mick also acts as a strategic advisor to clients with respect to a variety of financial, business, and legal issues. His experience crosses a number of industries including life sciences and biotechnology, consumer products, financial services, health care, industrial services, telecommunications, home furnishings, home textiles, and media. Mick’s clients range in size from early-stage companies and private equity firms to large, multi-national corporations.
Mick also has experience in representing financial institutions, including commercial and investment banks, in connection with debt and equity financings. He has particular experience representing non-bank lenders in their lending activities including through the provision of growth capital and mezzanine financings. Mick actively represents troubled companies and their capital providers in complex, distressed financial transactions. He also provides corporate advice to boards of directors and financial advisors in non-judicial workouts.
Mick is actively involved in the community. He serves as Chairman of the Board of First Step Staffing – a (501(c)(3) staffing company that provides employment for individuals who have recently experienced homelessness and for returning citizens. Mick also serves on the Board of Directors of the Westside Future Fund – a 501(c)(3) fund formed by Atlanta’s public, private, and philanthropic partners who believe in the future of Atlanta’s Westside.
Mick is ranked by Chambers USA as a leading Corporate/Mergers & Acquisitions lawyer. He has been recognized each year since 2013 by The Best Lawyers in America® for Mergers & Acquisitions Law, Corporate Law, Bankruptcy and Creditor Debtor Rights, and Insolvency and Reorganization Law. In addition, Mick has been recommended by Legal 500 US for Mergers & Acquisitions. In addition, the Daily Report recognized him as one of the “Most Effective Dealmakers of the Year” in 2019.
*Represented a multi-media and technology company that produces content principally for the hunting, fishing, and outdoor markets in the acquisition of a technical hunting apparel company.
*Represented an IT consulting and services company in its acquisition of a technology and management consulting services firm in a privately negotiated transaction.
*Represented a growth equity firm and its partners in debt and equity investments in primary and secondary markets involving leading technology companies.
*Represented a leading venture capital firm in Montana in connection with the acquisition of a cybersecurity training and awareness platform by a company that provides cloud cybersecurity services for email, data, and web.
*Represented a private investment firm in connection with its acquisitions of a wholesale supplier of retail store displays, a provider of rigging and other industrial services, and a maker of branded and private label sun-care products.
*Represented an investment firm and its investment partner in the acquisitions of two leading companies in the specialty adhesives manufacturing sector.
*Represented a private equity firm in its recent equity and debt investment in one of the largest distributors of medical imaging equipment in the US.
*Represented a non-profit tissue bank in the business of procuring, processing, and distributing human musculoskeletal, skin, and ocular tissue in its recent formation of a for-profit subsidiary for its musculoskeletal and skin division and the spin out of such subsidiary to an investment group led by a growth equity fund.
*Represented a company that researches, develops, and markets regenerative medicine products in the sale of its culture-expanded mesenchymal stem cell (ceMSC) business to a Swiss subsidiary of an Australian-based regenerative medicine company, the sale of the a product line for the repair, replacement, and/or reconstruction of bone defects to a medical devices company, and the exclusive collaboration and license agreement with a biotechnology company.
*Represented an equity investment firm in connection with its acquisitions of a New York-based company that specializes in plug-in adapters for mobile phones and a company that is nationally recognized as a workforce expert for the logistics industry.
*Represented two private equity funds in connection with a variety of mezzanine and growth equity investments in several companies.
*Represented a private equity fund, a private mezzanine debt and equity investment firm, and a real estate investment firm in the formation of private equity funds.
*Experience gained by attorney prior to joining Kilpatrick
Insights View All
University of Chicago Law School J.D. (1989)
University of Washington B.A. (1986) cum laude, Phi Beta Kappa
New York (1990)
First Step Staffing, Board of Directors, Chairman
Georgia Bar Association, Member
Westside Future Fund, Board of Directors, Member
While we are pleased to have you contact us by telephone, surface mail, electronic mail, or by facsimile transmission, contacting Kilpatrick Townsend & Stockton LLP or any of its attorneys does not create an attorney-client relationship. The formation of an attorney-client relationship requires consideration of multiple factors, including possible conflicts of interest. An attorney-client relationship is formed only when both you and the Firm have agreed to proceed with a defined engagement.
DO NOT CONVEY TO US ANY INFORMATION YOU REGARD AS CONFIDENTIAL UNTIL A FORMAL CLIENT-ATTORNEY RELATIONSHIP HAS BEEN ESTABLISHED.
If you do convey information, you recognize that we may review and disclose the information, and you agree that even if you regard the information as highly confidential and even if it is transmitted in a good faith effort to retain us, such a review does not preclude us from representing another client directly adverse to you, even in a matter where that information could be used against you.